ESR1 and breast cancer: YY1 level was significantly overexpressed in the ER+/PR+/HER-2- subtype of BC patients with synchronous metastasis at staging compared with metachronous metastasis and healthy subjects (p < 0.001), and it correlated significantly with SUVmax (r = 0.48).